Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Gains from Investment Securities (2016 - 2025)

Traws Pharma (TRAW) has disclosed Gains from Investment Securities for 14 consecutive years, with $26.7 million as the latest value for Q4 2025.

  • For Q4 2025, Gains from Investment Securities changed N/A year-over-year to $26.7 million; the TTM value through Dec 2025 reached $26.5 million, changed N/A, while the annual FY2025 figure was $1.3 million, 212.77% up from the prior year.
  • Gains from Investment Securities hit $26.7 million in Q4 2025 for Traws Pharma, up from $3000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $26.7 million in Q4 2025 and bottomed at -$530000.0 in Q3 2021.
  • Average Gains from Investment Securities over 5 years is $2.6 million, with a median of $365792.0 recorded in 2021.
  • Year-over-year, Gains from Investment Securities tumbled 846.43% in 2021 and then soared 1715.83% in 2023.
  • Traws Pharma's Gains from Investment Securities stood at -$530000.0 in 2021, then surged by 459.66% to $1.9 million in 2022, then tumbled by 51.93% to $916352.0 in 2023, then crashed by 94.39% to $51381.0 in 2024, then skyrocketed by 51779.1% to $26.7 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $26.7 million, $3000.0, and -$146000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.